281 related articles for article (PubMed ID: 9543164)
1. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.
Thompson SD; Franklyn JA; Watkinson JC; Verhaeg JM; Sheppard MC; Eggo MC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1336-41. PubMed ID: 9543164
[TBL] [Abstract][Full Text] [Related]
2. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.
Shingu K; Fujimori M; Ito K; Hama Y; Kasuga Y; Kobayashi S; Itoh N; Amano J
Endocr J; 1998 Feb; 45(1):35-43. PubMed ID: 9625444
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours.
Myoken Y; Myoken Y; Okamoto T; Sato JD; Kan M; McKeehan WL; Nakahara M; Takada K
J Pathol; 1996 Apr; 178(4):429-36. PubMed ID: 8691322
[TBL] [Abstract][Full Text] [Related]
4. Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells.
Cocks HC; Thompson S; Turner FE; Logan A; Franklyn JA; Watkinson JC; Eggo MC
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E460-9. PubMed ID: 12746216
[TBL] [Abstract][Full Text] [Related]
5. Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signaling.
Ramsden JD; Buchanan MA; Egginton S; Watkinson JC; Mautner V; Eggo MC
Endocrinology; 2005 Jul; 146(7):2895-902. PubMed ID: 15817662
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1.
Kranenburg AR; Willems-Widyastuti A; Mooi WJ; Saxena PR; Sterk PJ; de Boer WI; Sharma HS
J Pathol; 2005 May; 206(1):28-38. PubMed ID: 15772985
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
[TBL] [Abstract][Full Text] [Related]
8. Increase of basic fibroblast growth factor (FGF) and FGF receptor messenger RNA during rat thyroid hyperplasia: temporal changes and cellular distribution.
Becks GP; Logan A; Phillips ID; Wang JF; Smith C; DeSousa D; Hill DJ
J Endocrinol; 1994 Aug; 142(2):325-38. PubMed ID: 7931005
[TBL] [Abstract][Full Text] [Related]
9. Expression of fibroblast growth factors in thyroid cancer.
Eggo MC; Hopkins JM; Franklyn JA; Johnson GD; Sanders DS; Sheppard MC
J Clin Endocrinol Metab; 1995 Mar; 80(3):1006-11. PubMed ID: 7533768
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated expression of dominant negative fibroblast growth factor (FGF) receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in mice.
Davies EL; Ramsden JD; Cocks H; Searle PF; Watkinson JC; Ueno H; Logan A; Franklyn JA; Mautner V; Eggo MC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4472-80. PubMed ID: 12970326
[TBL] [Abstract][Full Text] [Related]
11. Changes in the immunohistochemical localisation of fibroblast growth factor-2, transforming growth factor-beta 1 and thrombospondin-1 are associated with early angiogenic events in the hyperplastic rat thyroid.
Patel VA; Hill DJ; Eggo MC; Sheppard MC; Becks GP; Logan A
J Endocrinol; 1996 Mar; 148(3):485-99. PubMed ID: 8778227
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor 1 (IGF-1) in multinodular goiters: a possible pathogenetic factor.
Maiorano E; Ambrosi A; Giorgino R; Fersini M; Pollice L; Ciampolillo A
Pathol Res Pract; 1994 Nov; 190(11):1012-6. PubMed ID: 7746734
[TBL] [Abstract][Full Text] [Related]
13. [Recent findings on the etiopathogenesis of multinodular goiter. II. Thyroid growth factors].
Francia G; Musumeci C; Daví MV; Azzolina LS; Zamboni G; Sussi PL
Chir Ital; 1991; 43(3-4):84-9. PubMed ID: 1782708
[TBL] [Abstract][Full Text] [Related]
14. Integrin expression in thyroid cells from normal glands and nodular goiters.
Vitale M; Bassi V; Fenzi G; Macchia PE; Salzano S; Rossi G
J Clin Endocrinol Metab; 1993 Jun; 76(6):1575-9. PubMed ID: 8501165
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions.
Ruggeri RM; Sciacchitano S; Trimarchi F; Barresi G; Trovato M
Eur J Histochem; 2007; 51(3):193-8. PubMed ID: 17921114
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry.
Deshmukh N; Scotson J; Dodson AR; Smith PH; Ke Y; Foster CS
Br J Urol; 1997 Dec; 80(6):869-74. PubMed ID: 9439399
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
St Bernard R; Zheng L; Liu W; Winer D; Asa SL; Ezzat S
Endocrinology; 2005 Mar; 146(3):1145-53. PubMed ID: 15564323
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues.
Hughes SE; Hall PA
Lab Invest; 1993 Aug; 69(2):173-82. PubMed ID: 7688835
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study.
Kimura ET; Kopp P; Zbaeren J; Asmis LM; Ruchti C; Maciel RM; Studer H
Thyroid; 1999 Feb; 9(2):119-25. PubMed ID: 10090310
[TBL] [Abstract][Full Text] [Related]
20. Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer.
Zammit C; Barnard R; Gomm J; Coope R; Shousha S; Coombes C; Johnston C
J Pathol; 2001 May; 194(1):27-34. PubMed ID: 11329138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
